Marie Heron Brings Truth Be Told to MS & Me Radio
Marie Heron, host of the popular Truth Be Told podcasts will bring them to our global radio station each Sunday at 6:30pm EST.Marie Heron...
Roche’s star MS medicine Ocrevus wins EU approval
ZURICH (Reuters) - The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion...
New Inroads Against Multiple Sclerosis
JAMA recently published their interviews with two MS Specaists focusing on the medical progress against multiple sclerosis (MS) in 2017 with the approval by the...
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
SOURCE Novartis- Breakthrough Therapy designation can expedite the development and review of therapies for serious conditions- In a pivotal Phase III study, oral fingolimod...
MS & Me Interviews: Yvonne deSousa Finds Giggles in an MS Life
They say laughter is the best medicine, and our guest this week on MS & Me Interviews, Yvonne deSousa, would agree. The author of MS...
Novartis multiple sclerosis drug Gilenya shows siginificant effect against pediatric MS in phase III...
Novartis MS Drug Gilenya shows siginificant effect in phase III trial: Against Pediatric MSNovartis’ multiple sclerosis (MS) drug Gilenya (fingolimod) has demonstrated significant effect...
